Skip to main content

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by InspireMD, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for InspireMD, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for InspireMD, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Berman MichaelDirector352,586Sep 23, 20262
Roubin Gary SDirector834,478Sep 23, 20264
Stuka PaulDirector667,871Sep 23, 202610
Gleason Shane ThomasChief Commercial Officer1,053,882May 21, 20263
Slosman MarvinCEO and President3,556,658May 13, 20262
Ward Scott R.Director237,096May 8, 20262
Cohen Raymond WDirector92,417Jan 16, 20261
Dearen Danny L.Director102,047Jan 16, 20261
Lawless Michael AChief Financial Officer691,695Jan 16, 20261
Tommasoli AndreaChief Operating Officer954,389Jan 16, 20261
Arnold KathrynDirector303,087Dec 31, 20251
Kester Thomas JDirector458,573Sep 17, 20250
Shore CraigCFO and CAO1,112,460Jan 10, 20250
Verta PatrickEVP Clinical/Medical Affairs311,532Jan 10, 20250
Rogers CampbellDirector27,960Oct 14, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 29, 2026 (view filing)May 272 daysStuka PaulDirectorPPurchase+20.0K$0.88+$17.6K+3.1%667.9K after
May 21, 2026 (view filing)Jan 27, 2025-May 19, 2026479 daysLateGleason Shane ThomasChief Commercial OfficerSSale−85.3K$2.22−$189.6K−7.5%1.05M after14 lots
May 15, 2026 (view filing)May 13-142 daysStuka PaulDirectorPPurchase+15.0K$1.16+$17.4K+2.4%647.9K after2 lots
May 13, 2026 (view filing)May 121 daySlosman MarvinCEO and PresidentPPurchase+21.0K$1.20+$25.2K+0.6%3.56M after
May 13, 2026 (view filing)May 8-115 daysStuka PaulDirectorPPurchase+75.6K$1.16+$88.0K+13.6%632.9K afterAmended2 lots
May 8, 2026 (view filing)May 6-72 daysWard Scott R.DirectorPPurchase+89.3K$1.15+$102.6K+60.4%237.1K after2 lots
May 8, 2026 (view filing)May 6-72 daysStuka PaulDirectorPPurchase+7.89K$1.14+$9.03K+1.5%531.6K after2 lots
May 8, 2026 (view filing)May 71 dayRoubin Gary SDirectorPPurchase+90.0K$1.18+$106.2K+12.1%834.5K after
Feb 23, 2026 (view filing)Dec 9, 202576 daysStuka PaulDirectorPPurchase+2.71K$1.81+$4.91K+0.7%391.6K afterAmended
Feb 2, 2026 (view filing)Jan 15-Feb 218 daysLateGleason Shane ThomasChief Commercial OfficerSSale−61.2K$1.62−$99.2K−5.1%1.14M after10 lots
Dec 8, 2025 (view filing)Dec 53 daysStuka PaulDirectorPPurchase+5.07K$1.86+$9.44K+1.3%388.9K after
Dec 5, 2025 (view filing)Dec 41 dayStuka PaulDirectorPPurchase+10.1K$1.85+$18.7K+2.7%383.8K after
Nov 13, 2025 (view filing)Nov 121 dayStuka PaulDirectorPPurchase+13.4K$1.62+$21.8K+3.7%373.7K after
Aug 1, 2025 (view filing)Jul 302 daysRoubin Gary SDirectorPPurchase+41.3K$2.42+$100.0K+7.3%608.4K after
Aug 1, 2025 (view filing)Jul 302 daysKester Thomas JDirectorPPurchase+31.0K$2.42+$75.0K+8.0%420.8K after
Aug 1, 2025 (view filing)Jul 302 daysSlosman MarvinCEO and PresidentPPurchase+10.3K$2.42+$25.0K+0.4%2.42M after
Aug 1, 2025 (view filing)Jul 302 daysStuka PaulDirectorPPurchase+20.7K$2.42+$50.0K+4.9%444.2K after
Dec 4, 2023 (view filing)Nov 304 daysRoubin Gary SDirectorPPurchase+50.0K$2.53+$126.5K+12.9%438.9K after
May 16, 2023 (view filing)May 124 daysStuka PaulDirectorPPurchase+175.0K$1.63+$285.3K+238.0%248.5K after
May 16, 2023 (view filing)May 124 daysStuka PaulDirectorPPurchase+350.0K$1.63+$570.5K–87.5K afterDerivative4 lots
May 16, 2023 (view filing)May 124 daysKester Thomas JDirectorPPurchase+61.2K$1.63+$99.8K+129.4%108.6K after
May 16, 2023 (view filing)May 124 daysKester Thomas JDirectorPPurchase+122.5K$1.63+$199.7K–30.6K afterDerivative4 lots
May 16, 2023 (view filing)May 124 daysBerman MichaelDirectorPPurchase+122.5K$1.63+$199.7KNew position122.5K after
May 16, 2023 (view filing)May 124 daysBerman MichaelDirectorPPurchase+245.0K$1.63+$399.3K–61.2K afterDerivative4 lots
May 16, 2023 (view filing)May 124 daysRoubin Gary SDirectorPPurchase+61.2K$1.63+$99.8K+35.5%233.5K after
May 16, 2023 (view filing)May 124 daysRoubin Gary SDirectorPPurchase+122.5K$1.63+$199.7K–30.6K afterDerivative4 lots
Aug 22, 2022 (view filing)Aug 184 daysRoubin Gary SDirectorPPurchase+35.5K$1.91+$67.8K+27.6%164.2K after
Dec 30, 2021 (view filing)Dec 282 daysRoubin Gary SDirectorPPurchase+16.4K$3.08+$50.5K+14.6%128.7K after
Dec 2, 2021 (view filing)Dec 11 dayStuka PaulDirectorPPurchase+12.0K$3.51+$42.2K+19.6%73.5K after
Nov 30, 2021 (view filing)Nov 29-301 dayStuka PaulDirectorPPurchase+21.5K$3.55+$76.5K+53.9%61.5K after2 lots
Nov 29, 2021 (view filing)Nov 263 daysStuka PaulDirectorPPurchase+1.20K$3.55+$4.26K+3.1%39.9K after
Nov 26, 2021 (view filing)Nov 242 daysStuka PaulDirectorPPurchase+18.3K$3.55+$65.1K+89.8%38.7K after
Nov 23, 2021 (view filing)Nov 22-231 dayStuka PaulDirectorPPurchase+20.4K$3.54+$72.2K+72,828.6%20.4K after2 lots
Nov 18, 2021 (view filing)Nov 171 dayRoubin Gary SDirectorPPurchase+25.9K$3.86+$100.1K+30.0%112.3K after2 lots
Aug 26, 2021 (view filing)Aug 251 dayRoubin Gary SDirectorPPurchase+22.2K$4.19+$93.2K+47.5%69.1K after